The Vanguard Group Files Disclosure on Mural Oncology Stake

The Vanguard Group, Inc. has disclosed its position regarding Mural Oncology plc, following Rule 8.3 of the Irish Takeover Panel Act, 1997. The filing, dated October 17, 2025, reveals that Vanguard holds a 1.67% stake in Mural Oncology, corresponding to 288,811 ordinary shares at $0.01 each. No short positions are reported.

The declaration also includes details on recent transactions. Specifically, Vanguard reported the sale of 32 ordinary shares at a price of $2.07 per unit on October 16, 2025. No other security trades, including derivatives, were noted in this disclosure.

The form further clarifies that Vanguard has not entered into any indemnity or dealing arrangements related to these securities. No agreements concerning options or derivatives are in place, and no Supplemental Form 8 is attached to this disclosure.